NCT00705666View on ClinicalTrials.gov

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

CompletedOBSERVATIONAL
Enrollment

789

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Hepatitis C, ChronicHepacivirus
Interventions
BIOLOGICAL

Peginterferon alfa-2b (SCH 54031)

Peginterferon alfa-2b as monotherapy or in combination with ribavirin will be administered according to the products' labeling.

DRUG

Ribavirin (SCH 18908)

Peginterferon alfa-2b as monotherapy or in combination with ribavirin will be administered according to the products' labeling.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00705666 - Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED) | Biotech Hunter | Biotech Hunter